YU2392A - Antibakterijska jedinjenja - Google Patents

Antibakterijska jedinjenja

Info

Publication number
YU2392A
YU2392A YU2392A YU2392A YU2392A YU 2392 A YU2392 A YU 2392A YU 2392 A YU2392 A YU 2392A YU 2392 A YU2392 A YU 2392A YU 2392 A YU2392 A YU 2392A
Authority
YU
Yugoslavia
Prior art keywords
antibacterial compounds
c6alkyl
compounds
hydrogen
c6alkynyl
Prior art date
Application number
YU2392A
Other languages
English (en)
Inventor
R.J. Ternansky
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of YU2392A publication Critical patent/YU2392A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

ANTIBAKTERIJSKA JEDINJENJA, opisana su jedinjenja formule u kojoj R je vodonik, C1-C6alkil, C2-C6alkenil, C2-C6alkinil, C3-C6cikloalkil ili C1-C6haloalkil. A i A' su nezavisno vodonik, C1-C6alkil, nitro, amino, petočlani ili šestočlani heterocikl koji sadrži atome azota ili sumpora C1-C6alkoksi ili fenil, i farmaceutsko prihvatljive soli tog jedinjenja.
YU2392A 1991-01-18 1992-01-10 Antibakterijska jedinjenja YU2392A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/643,244 US5077287A (en) 1991-01-18 1991-01-18 3-thiazolylthio carbacephem antibacterial agents

Publications (1)

Publication Number Publication Date
YU2392A true YU2392A (sh) 1994-12-28

Family

ID=24579974

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2392A YU2392A (sh) 1991-01-18 1992-01-10 Antibakterijska jedinjenja

Country Status (21)

Country Link
US (1) US5077287A (sh)
EP (1) EP0495585A1 (sh)
JP (1) JPH04321686A (sh)
KR (1) KR920014810A (sh)
CN (1) CN1063284A (sh)
AU (1) AU642334B2 (sh)
BR (1) BR9200058A (sh)
CA (1) CA2058592C (sh)
CZ (1) CZ281909B6 (sh)
FI (1) FI920110A7 (sh)
HU (1) HUT60268A (sh)
IE (1) IE920084A1 (sh)
IL (1) IL100575A (sh)
MX (1) MX9200105A (sh)
MY (1) MY131300A (sh)
NO (1) NO301328B1 (sh)
NZ (1) NZ241250A (sh)
PT (1) PT99984B (sh)
RU (1) RU2107067C1 (sh)
YU (1) YU2392A (sh)
ZA (1) ZA9225B (sh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179088A (en) * 1990-02-12 1993-01-12 Eli Lilly And Company 1-carba(dethia)cephalosporin antibiotics
US5272265A (en) * 1990-02-12 1993-12-21 Eli Lilly And Company 3-(substituted or unsubstituted) thiazolo-1-carba (1-dethia)cephems
IL100576A (en) * 1991-01-18 1995-11-27 Eli Lilley And Company Cephalosporin antibiotics
JP3238209B2 (ja) * 1992-09-30 2001-12-10 塩野義製薬株式会社 チオメチルチオカルバセファロスポリン誘導体
US5525599A (en) * 1993-07-21 1996-06-11 Eli Lilly And Company 7-substituted-amino-3-substituted-3-cephem-4-carboxylic acids
DE4333697A1 (de) * 1993-10-02 1995-04-06 Merck Patent Gmbh Verfahren zur Herstellung von 3-Aminopyridinen aus 3-Nitropyridinen
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US5698547A (en) * 1994-04-01 1997-12-16 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
MX9604505A (es) * 1994-04-01 1997-11-29 Microcide Pharmaceuticals Inc Antibioticos de cefalosporina.
US5688786A (en) * 1994-04-01 1997-11-18 Microcide Pharmaceuticals, Inc. β-lactam antibiotics
US5498777A (en) * 1994-07-20 1996-03-12 Merck & Co., Inc. 3-thioheteroaryl cephalosporin compounds, compositions and methods of use
US5565445A (en) * 1995-02-22 1996-10-15 Merck & Co., Inc. 3-thioheteroaryl 1-carba-1-dethiacephalosporin compounds, compositions and methods of use
AU5985596A (en) * 1995-05-31 1996-12-18 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
AU7126198A (en) * 1997-04-17 1998-11-11 Microcide Pharmaceuticals, Inc. Improved beta-lactam antibiotics
US6025352A (en) * 1997-09-29 2000-02-15 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US6030965A (en) * 1997-09-30 2000-02-29 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
US20080146535A1 (en) * 2003-04-30 2008-06-19 Tomasz Glinka Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors
JP2006525340A (ja) * 2003-04-30 2006-11-09 トライン・ファーマシューティカルズ・インコーポレイテッド カルバセフェムβ−ラクタム系抗生物質
AU2008316688A1 (en) * 2007-10-25 2009-04-30 Achaogen, Inc. Carbacephem beta-lactam antibiotics
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics
WO2010123997A1 (en) * 2009-04-22 2010-10-28 Achaogen, Inc. Carbacephem beta-lactam antibiotics
EP2536410B1 (en) 2010-02-18 2015-09-23 Merck Sharp & Dohme Corp. Substituted pyrimidine derivatives and their use in treating viral infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
JPS60174787A (ja) * 1984-02-21 1985-09-09 Kyowa Hakko Kogyo Co Ltd ３位置換カルバセフエム化合物
JPH0653739B2 (ja) * 1984-11-15 1994-07-20 協和醗酵工業株式会社 ３位置換カルバセフエム化合物
IL100576A (en) * 1991-01-18 1995-11-27 Eli Lilley And Company Cephalosporin antibiotics

Also Published As

Publication number Publication date
ZA9225B (en) 1993-07-02
FI920110L (fi) 1992-07-19
CN1063284A (zh) 1992-08-05
HUT60268A (en) 1992-08-28
FI920110A0 (fi) 1992-01-10
IE920084A1 (en) 1992-07-29
US5077287A (en) 1991-12-31
PT99984A (pt) 1993-01-29
IL100575A0 (en) 1992-09-06
JPH04321686A (ja) 1992-11-11
AU1013592A (en) 1992-07-23
KR920014810A (ko) 1992-08-25
BR9200058A (pt) 1992-09-08
NO301328B1 (no) 1997-10-13
CZ281909B6 (cs) 1997-03-12
EP0495585A1 (en) 1992-07-22
NO920103D0 (no) 1992-01-08
NZ241250A (en) 1993-02-25
AU642334B2 (en) 1993-10-14
CA2058592C (en) 2001-12-25
RU2107067C1 (ru) 1998-03-20
HU9200081D0 (en) 1992-03-30
IL100575A (en) 1996-11-14
CA2058592A1 (en) 1992-07-19
CS1192A3 (en) 1992-08-12
PT99984B (pt) 1999-06-30
FI920110A7 (fi) 1992-07-19
MX9200105A (es) 1992-07-01
MY131300A (en) 2007-08-30
NO920103L (no) 1992-07-20

Similar Documents

Publication Publication Date Title
YU2392A (sh) Antibakterijska jedinjenja
NZ333987A (en) Inhibitors of cysteine and serine proteases particularly cathepsin K that are useful in the treatment of diseases that cause bone loss
HUT67285A (en) Cyclic ureas and analogues and pharmaceutical compositions
NO963053L (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
KR987000261A (ko) 벤즈아미드옥심 유도체, 그의 제법 및 농원예용 살균제 (Benzamidoxime Derivative, Proecss for Production Thereof,and Agrohorticultural Bactericide)
NZ329303A (en) 1,10-dioxo-4-hydroxy-1,2,5,10-tetrahydro pyridazino[4,5-b] quinoline derivatives and medicaments
NO944930L (no) Hemming av dysfunksjonell uterin blödning
DE69631865D1 (de) Sulfonamide mit Elastase inhibierender Wirkung
DE69221003D1 (de) Antibiotische Carbapenemderivate
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
ATE298570T1 (de) Antibakterielle verbindungen
NO304486B1 (no) Oksazolidonderivater og anvendelser derav, og midler og medisinske preparater omfattende slike oksazolidonderivater
DK166151C (da) Pristinamycin iib-derivater, deres fremstilling og farmaceutiske praeparater deraf
NO905620L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
MX9301701A (es) Derivados de fenotiazina para el tratamiento de la isquema y la hipoxia, composiciones farmaceuticas que los contienen y procedimiento para la preparacion de dichas composiciones farmaceuticas.
ES2141096T3 (es) Compuestos de cefalosporina y composiciones farmaceuticas de los mismos.
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
NO955197L (no) Nye carbosykliske nukleoside midler som er anvendbare som selektive inhibitorer av pro-inflammatoriske cytokiner
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
EP1238974A4 (en) HETEROCYLIC DERIVATIVES AND DRUGS
AU6399598A (en) N-sulphonyl and n-sulphinyl amino acid amides as microbicides
FR2642648B1 (fr) Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
MY131365A (en) Carbamic acid derivatives
DE69523819D1 (de) Quinolin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
DE69112095D1 (de) 1-Phenoxycarbonyl-2-Pyrrolidon-Derivate und nootrope Wirkstoffe.